MS drug has fewer injection reactions
- Published: 04 March 2008 18:15
- Author:Steve Ford | More by this Author
- Last Updated: 04 March 2008 18:15
A new formulation of interferon beta-1a (Rebif) has been launched for relapsing remitting multiple sclerosis, which has a near three-fold reduction in injection-site reactions.
Sign in
In order to continue you need to be a registered user. If you would like to register to Nursing Times then click here.
